Cover
Cover - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Apr. 10, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K/A | ||
Amendment Flag | true | ||
Amendment Description | Amendment No. 1 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2023 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 001-38418 | ||
Entity Registrant Name | Cocrystal Pharma, Inc. | ||
Entity Central Index Key | 0001412486 | ||
Entity Tax Identification Number | 35-2528215 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Address, Address Line One | 19805 North Creek Parkway | ||
Entity Address, City or Town | Bothell | ||
Entity Address, State or Province | WA | ||
Entity Address, Postal Zip Code | 98011 | ||
City Area Code | (877) | ||
Local Phone Number | 262-7123 | ||
Title of 12(b) Security | Common Stock, par value | ||
Trading Symbol | COCP | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 18.5 | ||
Entity Common Stock, Shares Outstanding | 10,173,790 | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction [Flag] | false | ||
Auditor Firm ID | 572 | ||
Auditor Name | Weinberg & Company , P.A | ||
Auditor Location | Los Angeles, California |